Encryption systems rely on “random” numbers, but conventional computers can’t generate them perfectly. New research shows that quantum physics can. By Alexander Nazaryan Researchers in Switzerland ...

BENGALURU, May 20 (Reuters) - AI is enabling Indian engineering hubs of global firms to quicken intellectual property generation and mitigate supply chain risks, a Daimler Truck (DTGGe.DE), opens new ...

BENGALURU, May 20 (Reuters) - AI is enabling Indian engineering hubs of global firms to quicken intellectual property ‌generation and mitigate supply chain risks, a Daimler Truck executive said ‌on ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

More than 100 years ago Hungarian-born mathematician George Pólya found himself trapped in a loop of social awkwardness. A professor at the Swiss Federal Institute of Technology Zurich, he enjoyed ...

Feb 15 (Reuters) - ByteDance will take steps to prevent the unauthorised use of intellectual property on its AI video generator Seedance 2.0, the Chinese technology firm said on Monday, following ...

TikTok's owner is behind the model Seedance 2.0, which is being greeted akin to OpenAI's Sora 2 in the industry, with major studios as well as SAG-AFTRA signaling alarm over its infringement potential ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...